Stocktoria

Adagene Inc. ADAG

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-02-09 · LEI

Adagene Inc. statistics & valuation

Market cap$195.2M
P / S25.5×
P / B5.5×
Net margin-229.6%
Return on equity-49.8%
Net cash$73.4M
Enterprise value USD$121.8M
Earnings yield EBIT/EV-17.6%
Return on capital-40.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-3423.40% -6048.90% -719.20% -860.60% -104.60% -32386.40% -229.60% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-3993.70% -6156.50% -711.20% -903.10% -131.00% -34835.40% -279.50% 2019202020212022202320242025
Return on equity (%)
-46.70% -96.20% -26.90% -66.20% -49.80% 2019202020212022202320242025
Shares outstanding
15.2M 43.9M 54.6M 54.1M 55.1M 58.9M 59.2M 2019202020212022202320242025
Net debt ($)
-$91.0M -$72.2M -$171.4M -$129.6M -$96.4M -$84.8M -$73.4M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-15.50% -50.30% -38.60% -52.50% -16.40% -37.40% -22.50% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
0.02× 0.17× 0.19× 0.01× 0.03× 2019202020212022202320242025
EPS ($)
-$1.10 -$2.67 -$1.46 -$1.48 -$0.35 -$0.59 -$0.30 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-279.5%-34835.4%-131.0%-903.1%-711.2%-6156.5%-3993.7%
Net margin-229.6%-32386.4%-104.6%-860.6%-719.2%-6048.9%-3423.4%
Return on assets-22.5%-37.4%-16.4%-52.5%-38.6%-50.3%-15.5%
Return on equity-49.8%-66.2%-26.9%-96.2%-46.7%47.4%28.8%
Debt / equity0.03×0.01×0.19×0.17×0.02×-0.03×-0.03×
Current ratio3.072.303.612.716.244.9014.47

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.